# Chiron Real Estate Inc.: overview

XRN · NYSE · CIK 1533615 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xrn.md) · [Financials](/companies/xrn/financials.md) · [Filings](/companies/xrn/filings.md) · [Insiders](/companies/xrn/insiders.md)

Latest reported revenue: [$39.7m](/filings/0001104659-26-093347.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-093347).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.3](/filings/0001104659-25-106984.md) | [35.2 d](/filings/0001104659-26-021956.md) | [34.6](/filings/0001104659-26-057206.md) | [38.0](/filings/0001104659-26-093347.md) | [37.2](/filings/0001104659-25-106984.md) | [38.4 d](/filings/0001104659-26-021956.md) | [38.1](/filings/0001104659-26-057206.md) | [39.7](/filings/0001104659-26-093347.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | [78.4%](/filings/0001104659-26-093347.md) | not reported | not reported | not reported | [74.8%](/filings/0001104659-26-093347.md) |
| Net margin | % | [9.9%](/filings/0001104659-25-106984.md) | [8.4% d](/filings/0001104659-26-021956.md) | [10.8%](/filings/0001104659-26-057206.md) | [1.5%](/filings/0001104659-26-093347.md) | [(13.6%)](/filings/0001104659-25-106984.md) | [(16.0%) d](/filings/0001104659-26-021956.md) | [4.3%](/filings/0001104659-26-057206.md) | [181.9%](/filings/0001104659-26-093347.md) |
| Diluted EPS | $ per share | [0.14](/filings/0001104659-25-106984.md) | not reported | [0.16](/filings/0001104659-26-057206.md) | [(0.06)](/filings/0001104659-26-093347.md) | [(0.45)](/filings/0001104659-25-106984.md) | not reported | [(0.06)](/filings/0001104659-26-057206.md) | [4.78](/filings/0001104659-26-093347.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [116](/filings/0001558370-24-002000.md) | [137](/filings/0001558370-25-001938.md) | [141](/filings/0001104659-26-021956.md) | [139](/filings/0001104659-26-021956.md) | [148](/filings/0001104659-26-021956.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [15.8%](/filings/0001558370-22-002518.md) | [14.6%](/filings/0001558370-25-001938.md) | [15.4%](/filings/0001104659-26-021956.md) | [4.8%](/filings/0001104659-26-021956.md) | [(4.6%)](/filings/0001104659-26-021956.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001558370-24-002000.md) | [0.20](/filings/0001558370-25-001938.md) | [1.13](/filings/0001104659-26-021956.md) | [0.06](/filings/0001104659-26-021956.md) | [(0.91)](/filings/0001104659-26-021956.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xrn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $66.7m | 1,776,626 |  | Added +633,396 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $24.8m | 661,149 |  | Added +20,958 |
| [HEARTLAND ADVISORS INC](/funds/937394.md) | 2026-06-30 | $20.9m | 556,260 |  | Added +112,175 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $20.7m | 551,824 |  | Added +2,060 |
| [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $16.3m | 433,924 |  | Added +55,448 |
| [Newtyn Management, LLC](/funds/1569241.md) | 2026-06-30 | $15.2m | 406,414 |  | New +406,414 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $13.8m | 367,408 |  | Added +10,885 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $12.7m | 336,271 |  | Reduced −2,475 |
| [Uniplan Investment Counsel, Inc.](/funds/1520710.md) | 2026-06-30 | $11.2m | 297,835 |  | Added +58,310 |
| [STIFEL FINANCIAL CORP](/funds/720672.md) | 2026-06-30 | $10.0m | 267,266 |  | Reduced −1,789 |

## Recent filings

[All 695 filings](/companies/xrn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 16:16 ET | [8-K](/filings/0001533615-26-000004.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001533615-26-000004 |
| 2026-08-17 | 16:51 ET | [8-K/A](/filings/0001104659-26-097910.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-097910 |
| 2026-08-10 | 16:06 ET | [10-Q](/filings/0001104659-26-093347.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093347 |
| 2026-08-05 | 17:10 ET | [8-K](/filings/0001104659-26-091251.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-091251 |
| 2026-08-03 | 16:36 ET | [8-K](/filings/0001104659-26-089818.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-089818 |
| 2026-07-17 | 16:40 ET | [8-K](/filings/0001104659-26-084665.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-084665 |
| 2026-07-06 | 16:30 ET | [8-K](/filings/0001104659-26-080771.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-080771 |
| 2026-07-02 | 17:26 ET | [8-K](/filings/0001104659-26-080436.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-080436 |
| 2026-06-02 | 16:30 ET | [8-K](/filings/0001104659-26-069515.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-069515 |
| 2026-05-20 | 17:24 ET | [8-K](/filings/0001104659-26-064620.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064620 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-021956.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7c6581dd-34ce-4b06-899e-67a4be03dbc3)

## About the filer

- CIK: 1533615
- Tickers: XRN, XRN-PA, XRN-PB
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:40 ET. No prices; not investment advice.